Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

A Worm's-Eye View of Immunity

Published: Tuesday, August 13, 2013
Last Updated: Tuesday, August 13, 2013
Bookmark and Share
Biology professor Dennis Kim seeks to understand the physiology and evolution of host-microbe interactions by studying a simple worm.

In 1998, scientists published the first complete genome of a multicellular organism — the worm Caenorhabditis elegans. At the same time, new technologies were emerging to help researchers manipulate genes and learn more about their functions.

Around that time, Dennis Kim was looking for a new research project to do during his upcoming postdoctoral fellowship at Massachusetts General Hospital (MGH). He decided to try to take advantage of the new genetic tools for studying C. elegans. In particular, he wanted to delve into what’s called the “innate immune system” — the first line of defense against invaders such as viruses and bacteria.

“It was a jump into a new area for me. We had no idea what we would find,” says Kim, who is now an associate professor of biology at MIT. “By studying worms we can take a much more basic evolutionary perspective on the function of the innate immune system. We think we can learn very basic principles in a simpler host organism and also gain some perspective on the evolution of the mammalian system as well.”

The innate, or nonspecific, immune system evolved very early on in primitive animals including worms and fruit flies. Vertebrate animals, which evolved later, also have a specific immune system, which targets pathogens very precisely with antibodies, killer T cells and other cells.

In vertebrates, the innate immune system identifies pathogens and serves as an early alert system, mobilizing the immune system to launch a more specific reaction. In worms, the innate system is the only defense.

In Kim’s studies of the C. elegans immune system, he chose to investigate how the worm defends itself against Pseudomonas aeruginosa, a bacterium that commonly infects people with suppressed immune systems. He has since identified many genes necessary for innate immunity, most of which are involved in signaling between the cells involved in the immune response.

“A lot of serendipity came into play, as seems to always happen in science,” Kim says. “We were able to find some genes in the worm that are required to protect the worm against pathogenic bacteria. Those genes turned out to be genes also required in humans and mice for innate immune defense.”

Science and medicine

Kim, the son of Korean immigrants, was born in Des Moines, Iowa. When he was 10, his family moved to Covina, Calif., a small city east of Los Angeles. His parents always encouraged him to “find something you love to do.” In high school, Kim was drawn to math, which he continued studying at the University of California at Berkeley while majoring in biophysics.

The summer after his sophomore year, Kim got a job working in a chemistry lab studying the biophysics of photosynthesis. One of his duties was going to the grocery store for bunches of spinach to grind up so the photosynthetic enzymes could be purified. The fresher the spinach, the better the results. “I became the most discriminating buyer of spinach you’ve ever seen,” he says.

During that summer, Kim became absorbed in studying how plants use sunlight to split water to make the oxygen we breathe, and got hooked on doing lab research. Most likely he would have continued studying biophysics exclusively, he says, if not for an accident that occurred after his junior year: While riding his motor scooter near Berkeley, he was hit by a car, fracturing his leg.

Kim spent several months rehabbing the leg, unable to attend his classes. During this time, he was fascinated by how well his doctors were able to heal his injury. “I was really impressed with that. I had no inkling of going to medical school at that time, but through that experience, human health came back into my sphere of thinking,” he says.

After graduating from Berkeley, Kim decided to pursue an MD/PhD at Harvard Medical School. For his PhD in biological chemistry, he studied enzymes involved in bacterial cell-wall synthesis, which are the targets of major classes of antibiotics. After earning his MD, he did an internship and residency in internal medicine at Brigham and Women’s Hospital (BWH) and a fellowship in infectious disease at MGH and BWH.

Although Kim now focuses mainly on lab research and teaching, he still sees patients at MGH. “I just really have always enjoyed trying to take care of sick people,” he says.

Complex interactions


Since arriving at MIT in 2005, Kim has expanded his research to focus on interactions between bacteria and C. elegans and how those interactions influence the worms’ behavior, stress physiology and aging.

For example, worms that eat harmful bacteria will then avoid that type of bacteria. Kim is looking for receptors in worm cells that interact with the molecules produced by the bacteria and trying to identify the genes and molecules involved in the resulting behavioral responses.

Many of the signaling pathways that appear to be involved in these behavioral responses are also found in humans, so Kim believes these studies could also shed light on the physiology of humans — whose bodies contain 10 times more bacterial cells than human cells. “It’s increasingly clear things we do to alter our microbial flora can have a pretty pronounced influence on our physiology,” he says.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Controlling RNA in Living Cells
Modular, programmable proteins can be used to track or manipulate gene expression.
Wednesday, April 27, 2016
Long-Term Drug Release
New tablet attaches to the lining of the GI tract, resists being pulled away.
Thursday, April 07, 2016
Pharmacy on Demand
New, portable system can be configured to produce different drugs.
Monday, April 04, 2016
A Programming Language for Living Cells
New language lets researchers design novel biological circuits.
Monday, April 04, 2016
Why Some Tumors Withstand Treatment
Mechanism uncovered that allows cancer cells to evade targeted therapies.
Thursday, March 17, 2016
Cancer Cells Remodel Environments Before Spreading
Researchers at MIT have found that the cancer cells remodel their environment to make it easier to reach nearby blood vessels.
Wednesday, March 16, 2016
Paving the Way for Metastasis
Cancer cells remodel their environment to make it easier to reach nearby blood vessels.
Tuesday, March 15, 2016
A New Way to Discover DNA Modifications
Researchers systematically find molecules that help regulate and protect DNA.
Wednesday, March 02, 2016
MIT Study: Carbon Tax Needed to Cut Fossil Fuel Consumption
Researchers at MIT have suggested that the technology-driven cost reductions in fossil fuels will lead the world to continue using all the oil, gas, and coal, unless governments pass new taxes on carbon emissions.
Thursday, February 25, 2016
Mapping Regulatory Elements
Systematically searching DNA for regulatory elements indicates limits of previous thinking
Wednesday, February 03, 2016
Curing Disease by Repairing Faulty Genes
New delivery method boosts efficiency of CRISPR genome-editing system.
Wednesday, February 03, 2016
Living a “Mixotrophic” Lifestyle
Some tiny plankton may have big effect on ocean’s carbon storage.
Tuesday, February 02, 2016
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
Friday, January 29, 2016
No More Insulin Injections?
Encapsulated pancreatic cells offer possible new diabetes treatment.
Tuesday, January 26, 2016
Engineering Foe into Friend
Bose Grant awardee Jacquin Niles aims to repurpose the malaria parasite for drug delivery.
Monday, January 25, 2016
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Immune Cells Remember Their First Meal
Scientists at the University of Bristol have identified the trigger for immune cells' inflammatory response – a discovery that may pave the way for new treatments for many human diseases.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Biosensor Detects Molecules Linked to Cancer, Alzheimer's and Parkinson's
Novel biosensor has been proven capable of detecting molecules associated with neurodegenerative diseases and some types of cancer.
Gene That Lowers Heart Attack Risk Identified
Individuals with a rare twelve-letter deletion from a gene on chromosome 17 have significantly reduced non-HDL cholesterol levels and a 35% lower than average risk of heart disease.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
"Sunscreen" Gene May Guard Against Melanoma
USC-led study reveals that melanoma patients with deficient or mutant copies of the gene are less protected from harmful ultraviolet rays.
Real-Time Imaging of Embryo Development Could Pave the Way
Researchers at IMCB have developed advanced microscopy technologies to monitor embryo development for more effective human reproduction therapies.
Testing Non-Breast/Ovarian Cancer Genes
Researchers have found that expanding gene panel beyond breast/ovarian cancer genes in these patients does not add any clinical benefit. Instead, testing has produced more questions than answers.
Visual Impairment, Blindness Cases in U.S. Expected to Double by 2050
Researchers at NIH have suggested that there is a need for increased screening and interventions to identify and address treatable causes of vision loss.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!